AJP - Lung Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 290: L1111-L1116, 2006. First published January 6, 2006; doi:10.1152/ajplung.00431.2005
1040-0605/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/L1111    most recent
00431.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.

Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro

Vivek Balasubramaniam,1 Anne M. Maxey,1 Brian W. Fouty,2 and Steven H. Abman1

1Pediatric Heart Lung Center, Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado; and 2Pulmonary Medicine, University of South Alabama, Mobile, Alabama

Submitted 10 October 2005 ; accepted in final form 5 January 2006


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Growth and development of the lung normally occur in the low oxygen environment of the fetus. The role of this low oxygen environment on fetal lung endothelial cell growth and function is unknown. We hypothesized that low oxygen tension during fetal life enhances pulmonary artery endothelial cell (PAEC) growth and function and that nitric oxide (NO) production modulates fetal PAEC responses to low oxygen tension. To test this hypothesis, we compared the effects of fetal (3%) and room air (RA) oxygen tension on fetal PAEC growth, proliferation, tube formation, and migration in the presence and absence of the NO synthase (NOS) inhibitor N{omega}-nitro-L-arginine (LNA), and an NO donor, S-nitroso-N-acetylpenicillamine (SNAP). Compared with fetal PAEC grown in RA, 3% O2 increased tube formation by over twofold (P < 0.01). LNA treatment reduced tube formation in 3% O2 but had no affect on tube formation in RA. Treatment with SNAP increased tube formation during RA exposure to levels observed in 3% O2. Exposure to 3% O2 for 48 h attenuated cell number (by 56%), and treatment with LNA reduced PAEC growth by 44% in both RA and 3% O2. We conclude that low oxygen tension enhances fetal PAEC tube formation and that NO is essential for normal PAEC growth, migration, and tube formation. Furthermore, we conclude that in fetal cells exposed to the relative hyperoxia of RA, 21% O2, NO overcomes the inhibitory effects of the increased oxygen, allowing normal PAEC angiogenesis and branching. We speculate that NO production maintains intrauterine lung vascular growth and development during exposure to low O2 in the normal fetus. We further speculate that NO is essential for pulmonary angiogenesis in fetal animal exposed to increased oxygen tension of RA and that impaired endothelial NO production may contribute to the abnormalities of angiogenesis see in infants with bronchopulmonary dysplasia.

vasculogenesis; lung development; pulmonary circulation; endothelium

FETAL LUNG ORGANOGENESIS AND MATURATION are characterized by distinctive changes in structure throughout the embryonic, pseudoglandular, canalicular, and saccular phases of development (35). Lung development is critically dependent on the highly regulated and synchronized temporal and spatial expression of diverse growth and transcription factors and receptors (10, 11, 23, 28, 31). Normal lung development occurs in the relatively hypoxic environment of the fetus, but few studies have addressed the direct effects of oxygen on pulmonary vascular growth or mechanisms that modulate the response to changes in oxygen tension during early development. Low oxygen enhances epithelial branching morphogenesis and vascular development in the mouse fetal lung explant model (33). However, the direct effects of changes in oxygen tension on fetal pulmonary artery endothelial cell (PAEC) growth and function and mechanisms that regulate vasculogenesis or angiogenesis in the normal fetus remain uncertain.

Premature birth interrupts the normal sequence of intrauterine lung development, resulting in the chronic lung disease known as bronchopulmonary dysplasia (BPD) (25). In addition to marked impairment of alveolarization, BPD is also characterized by dysmorphic vascular growth, which contributes to abnormal gas exchange, and the development of pulmonary hypertension (1, 8, 17, 18). Mechanisms that impair vascular growth after premature birth are uncertain, but exposure of the immature lung to marked elevations of oxygen tension may induce oxidant lung injury or directly inhibit lung growth (2, 8, 18).

In the developing fetus, the oxygen tension seen by the fetal lung is much lower than the ambient oxygen concentrations in standard tissue culture. These levels correspond to a PO2 that is ~22–25 Torr, which in vitro is equivalent to an FIO2 that is ~3% (16, 32). This level of fetal oxygen tension is necessary for normal embryonic (7), vascular (22, 33), and cardiac development (36). Fetal lung branching morphogenesis in vitro is enhanced by culture in low oxygen tension compared with room air (14, 33). Human fetal lung explants that were cultured at fetal oxygen tension had increased expression of vascular endothelial growth factor (VEGF) compared with explants cultured in room air (3) and inhibition of VEGF impaired lung vascular growth and airway branching (33). One of the downstream effectors of VEGF signaling, nitric oxide (NO), exhibits reciprocal regulation with VEGF (12, 13, 20, 24, 30).

Recent studies have suggested that NO may play a critical role in lung angiogenesis, especially during low oxygen tension. A recent study demonstrated abnormal lung vascular growth and abnormal spatial orientation of the pulmonary vasculature in endothelial nitric oxide synthase (eNOS) deficient fetal mice, beginning in late gestation (15). In addition, eNOS-deficient neonatal mice have an increased susceptibility to hypoxia induced inhibition of lung growth (5). In contrast to wild-type mice, mild hypoxia (16% oxygen) in the postnatal period impaired alveolarization and reduced lung parenchymal vascular volume in eNOS-deficient mice (5). These studies suggest that NO modulates or sustains lung angiogenesis and alveolarization and may play an adaptive role to preserve lung growth during fetal and neonatal life.

Therefore, we hypothesize that low oxygen tension during fetal life enhances pulmonary endothelial cell growth and function and that NO modulates the fetal PAEC response to changes in oxygen tension. In addition, we hypothesize that the exposure of fetal PAEC to the relative hyperoxia of room air will result in abnormalities of PAEC growth and function. To test this hypothesis, we studied fetal PAEC growth, survival, migration, and tube formation under fetal (3% O2) and postnatal (room air) oxygen tensions and the effect of an NOS inhibitor and an NO donor on PAEC exposed to these different oxygen tensions.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Isolation and culture of fetal ovine PAEC. All procedures and protocols were reviewed and approved by the Animal Care and Use Committee at the University of Colorado Health Sciences Center. Left and right main pulmonary arteries were isolated from late-gestation fetal lambs from mixed-breed (Columbia-Rambouillet) pregnant ewes at 135 days of gestation (term = 147 days). The ewe and fetus were anesthetized with intravenous pentobarbital sodium. The left and right main pulmonary arteries were isolated under direct visualization in a sterile manner and transferred to ice-cold Dulbecco’s modified Eagle’s medium (DMEM; Sigma, St. Louis, MO). The adventitia was removed from the pulmonary artery segment and opened to expose the endothelial surface. After a brief period of trypsin digestion (5 min), the endothelial surface was gently removed with a cell scraper, and the cells were transferred to a 150-mm cloning dish. Cells were cultured in DMEM with 20% fetal bovine serum (FBS), 1% L-glutamine, and 1% penicillin-streptomycin in humidified incubators (Forma Scientific, Marietta, OH) at 37°C in room air, 5% CO2, and balance nitrogen. Pure populations of fetal PAEC were subcloned based on their morphological appearance with cloning rings (Sigma). Cells were confirmed as endothelial cells at each passage by immunohistochemistry for eNOS, VE-cadherin, absence of desmin, and the uptake of dil-Ac-LDL. Cells from passages 6–8 were utilized for the experiments described below.

Tube formation assay. We assayed the ability of PAEC to form vascular structures in vitro by plating on EHS Matrigel. EHS Matrigel (BD Pharmingen, San Jose, CA) was seeded into 24-well tissue culture dishes (200 µl/well) and allowed to polymerize at 37°C for 1 h. Fetal ovine PAEC were seeded at a density of 4 x 104 cells/well in DMEM supplemented with 5% FBS with and without N{omega}-nitro-L-arginine (LNA, 2 mM) and with and without S-nitroso-N-acetylpenicillamine (SNAP, 5 µm). The cells were incubated for 12 h under 3% O2 or room air. PAEC were able to form tube-like branching structures on Matrigel, but these structures regressed by 18 h. Medium was removed, and the cells were fixed with 4% paraformaldehyde for 10 min. Pattern recognition and branch point counting were performed on at least four high-power fields (hpf) per well from each of four wells (29).

Cell migration assay. Cell migration was assayed with the Cell Invasion Assay Kit (ECM 550; Chemicon, Temecula, CA) that utilizes a modified Boyden chamber containing an 8-µm pore-size polycarbonate membrane, over which a thin layer of ECMatrix has been layered. Cells were seeded at a density of 1.5 x 105 cells/well to the upper chamber in serum-free DMEM. In the lower chamber, DMEM with 10% FBS with and without LNA (2 mM) and with and without SNAP (5 µm) was added. The cells were allowed to incubate for 24 h in either 3% O2-5% CO2-balance nitrogen or in 16% O2-5% CO2-balance nitrogen. Noninvading cells were removed from the upper side of the upper chamber. The lower side of the upper chamber was stained, and the number of cells on the lower chamber was counted at x40 magnification, using four fields per membrane. Each condition was repeated four times. The results are expressed as an average for each condition.

Cell growth. Fetal PAEC (passage 7) were plated at 4 x 104 cells/well and allowed to adhere overnight. Cells were growth arrested in DMEM supplemented with 0.5% FBS for 48 h. Cells were then grown in the following environments: low oxygen (3% O2) or in room air. Cells were grown in DMEM supplemented with 10% FBS in the presence or absence of an NOS inhibitor LNA (2 mM, Sigma) and in the presence or absence of the NO donor SNAP (5 µM, Calbiochem). The dose of LNA has been previously shown to inhibit proliferation and VEGF-dependent response in bovine aortic endothelial cells (34). SNAP spontaneously degrades and releases NO when kept in solution at room air and is depleted after 24 h in solution. In the control conditions a similar volume of this "depleted" SNAP was added. Cells were removed from wells by 0.25% trypsin/0.53 mM EDTA digestion and counted on days 0, 1, and 2. Cells from four wells were counted with a hemocytometer, and the results were averaged for each time point.

Cell cycle analysis. Cell cycle was determined by flow cytometry of propidium iodide staining. Cells from the growth assay above were collected by centrifugation (430 g for 10 min), washed with phosphate-buffered saline (PBS), and recollected by centrifugation. The cells were stained with Krishan’s solution [propidium iodide, Na-citrate, 1% Nonidet P-40 (NP-40), and RNase] overnight (19) and were analyzed in the University of Colorado Health Sciences Flow cytometry core using a Beckman (Miami, FL) Epics-XL flow cytometer. To determine the fractions of the population of PAEC in each phase of the cell cycle (G0/G1, S, G2/M), histograms of DNA content were analyzed using Modfit LT software (Verity Software, Topsham, ME).

Apoptosis assay. To quantify the number of apoptotic cells under the conditions described above, cells were seeded at a density of 1 x 104 cells/well in four chambered slides and incubated in DMEM with 10% FBS in the presence or absence of LNA (2 mM) in either 3% O2-5% CO2-balance nitrogen or in 16% O2-5% CO2-balance nitrogen. Cells were stained with 4',6-diamidine-2-phenylindole dihydrochloride (DAPI; Vectashield, H1200, Vector), and the number of condensed nuclei was counted in at least six hpf per sample from each of four wells. Western blot analysis was also performed, as described below, to assay for changes in the ratio of Bax to Bcl-2, that would suggest a shift toward apoptosis.

Western blot analysis. Cells at days 0, 1, and 2 were washed with ice-cold PBS and lysed in radioimmunoprecipitation buffer (PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml PMSF, 16 µl/ml aprotinin, and 1 mM sodium orthovanadate). Cell lysate was scraped off dishes, incubated 20 min on ice with occasional agitation, and centrifuged at 10,000 g for 10 min at 4°C. Protein content in the supernatant was determined by the Bradford method, using bovine serum albumin as the standard (6). Briefly, 10 µg of protein sample per lane were resolved by SDS-polyacrylamide gel electrophoresis, and proteins from the gel were transferred to nitrocellulose membrane. Blots were blocked 1 h in 5% nonfat dry milk in Tris-buffered saline (TBS) with 0.1% Tween 20. These blots were incubated for 1 h at room temperature with rabbit anti-mouse polyclonal Bax (1:200; Santa Cruz Biotech, SC526) and rabbit anti-human Bcl-2 (1:200; Santa Cruz Biotech, SC492), diluted in 5% nonfat dry milk in TBS with 0.1% Tween 20. Blots were incubated for 1 h at room temperature with goat anti-rabbit IgG-horseradish peroxidase antibody (Santa Cruz Biotech, SC2054). After being washed, bands were visualized by enhanced chemiluminescence (ECL+ kit; Amersham Pharmacia Biotech, Buckinghamshire, UK). Purified protein was run as a control and the band that comigrated with the molecular size as identified by the manufacturer for the protein of interest. The blots were then stripped and reprobed with an antibody to beta-actin (Sigma, A5316). Densitometry was performed using NIH Image (version 1.61). Changes in protein expression were analyzed after normalization for beta-actin expression.

Statistical analysis. Data are presented as means ± SD. Statistical analysis was performed with the Prism 4 software package (GraphPad Software, San Diego, CA). Statistical comparisons were made by analysis of variance and Bonferroni posttest. P < 0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
In vitro angiogenesis is dependent on oxygen tension and NO. Exposure of PAEC to 3% oxygen increased branch points by 114% compared with room air (16.4 ± 2 vs. 7.3 ± 3 branch points per hpf; P < 0.01; Figs. 1, A vs. B, and 2). NOS inhibition did not affect the number of branch points in room air (7.3 ± 2 branch pts/hpf; Fig. 1C). In contrast, LNA treatment during exposure to 3% oxygen decreased the number of branch points (7.6 ± 2 branch pts/hpf; P < 0.01; Fig. 1D) to levels observed in room air (Fig. 2). Treatment of PAEC with the NO donor SNAP increased the number of branch points of PAEC maintained in room air (Fig. 1E) (12 ± 2 branch points/hpf, P < 0.01, Fig. 2). SNAP treatment did not have an effect on the number of branch points in 3% oxygen [16.6 ± 2 branch pts/hpf, P = not significant (ns), Fig. 2]. The addition of SNAP during NOS inhibition in room air increased the number of branch points (Fig. 1, E vs. B) to similar values that were observed in 3% oxygen (14.5 ± 2 branch pts/hpf, Fig. 2). The addition of SNAP to LNA treated fetal PAEC in 3% oxygen increased the number of branch points (Fig. 1F) to levels observed in the 3% control group (17 ± 1 branch pts/hpf, Fig. 2). All reported values are means ± SD for and n = 4 in each group.


Figure 1
View larger version (40K):
[in this window]
[in a new window]
  		Fig. 1. Nitric oxide synthase (NOS) inhibition impairs vascular tube formation in Matrigel. Fetal ovine pulmonary endothelial cells (PAEC) were plated in 5% FBS in room air (RA, A), 3% oxygen (B), RA with N{omega}-nitro-L-arginine (LNA, 2 mM; C), 3% oxygen with LNA (D), RA with LNA + S-nitroso-N-acetylpenicillamine (SNAP, 5 µM) (E), and 3% oxygen with LNA + SNAP (F). There is a reduction in tube-like structure in RA vs. 3% oxygen. NOS inhibition has no effect in RA but reduces vascular tube growth in 3% oxygen. SNAP treatment improves tube formation in RA and reverses the effect of LNA in 3% oxygen.

 

Figure 2
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 2. In vitro branch point counting is reduced in fetal PAEC exposed to RA and NOS inhibition. There was no difference in the number of branch points/high-power field (hpf) in RA or RA with LNA. In 3% oxygen there was a significant increase in branch points (*P < 0.01) that was reduced to levels seen in RA with the addition of LNA. The addition of SNAP + LNA increased the number of branch points in RA to levels comparable to those seen in 3% oxygen. The addition of SNAP to LNA was able to restore branch point numbers to those seen with control in 3% oxygen. Error bars represent SD from means.

 
Fetal ovine PAEC migration is dependent on functional NOS. There was no difference in PAEC migration during exposure to room air or 3% oxygen (Fig. 3). In room air, LNA treatment decreased PAEC migration by 9.5% from baseline values (119 ± 8 vs. 108 ± 11 cells/hpf, P < 0.05, Fig. 3) and by 10.6% under 3% oxygen conditions (119 ± 6 vs. 106 ± 8 cells/hpf, P < 0.01, Fig. 3). Treatment with the NO donor SNAP did not significantly increase cell migration in room air (122 ± 10 cells/hpf) or 3% oxygen (125 ± 12 cells/hpf) but did reverse the reduction in cell migration seen with NOS inhibition.


Figure 3
View larger version (19K):
[in this window]
[in a new window]
  		Fig. 3. Fetal PAEC migration is reduced by NOS inhibition. Shown is the number of ovine fetal PAEC per hpf that migrated through a layer of Matrigel and through a membrane toward the chemotactic stimulus of 10% FBS (Control, solid bars), 10% FBS plus LNA (2 mM, open bars), 10% FBS plus LNA (2 mM) + SNAP (5 µM) (diagonally hatched bars), or 10% FBS plus SNAP (5 µM) (vertically hatched bars). Under RA conditions LNA impaired PAEC migration (*P < 0.05). Oxygen at 3% further reduced PAEC migration with LNA treatment (**P < 0.01). The addition of SNAP to LNA was able to restore migration to control levels in both RA and 3% oxygen. Error bars represent SD from means.

 
Low oxygen tension and NOS inhibition blunt fetal ovine PAEC growth. In room air, fetal PAEC number increased by 97% from baseline (3.7 ± 0.5 x 104 cells) at 48 h but only by 47% in 3% O2 (7 ± 0.8 x 104 vs. 5.2 ± 0.3 x 104 cells; P < 0.01, Fig. 4A). Compared with controls, LNA treatment in room air attenuated the increase in cell number at 24 (no change compared with day 0) and 48 h to only a 57% increase from day 0 (5.7 ± 0.2 x 104 cells; P < 0.05 vs. control, Fig. 4B). During exposure to 3% oxygen, LNA treatment had a more striking effect, resulting in no increase in cell number at 24 and 48 h (P < 0.01, Fig. 4C). Under room air conditions, the addition of SNAP did not have an effect on PAEC number (Fig. 4B). In 3% oxygen conditions, SNAP increased PAEC number by 72% (6.4 ± 0.6 x 104 cells) at 24 h and by 94% (7.2 ± 0.7 x 104 cells) at 48 h compared with day 0 (P < 0.001, Fig. 4C), which was similar to changes in cell number seen in room air. In room air, the addition of SNAP to LNA increased PAEC number from baseline by 77% at 24 h (6.5 ± 1.3 x 104 cells; P < 0.01 compared with control and LNA alone, Fig. 4B) with no further increase in cell number at 48 h (Fig. 4B). The addition of SNAP to LNA in 3% oxygen increased PAEC number from baseline by 57% at 24 h (5.8 ± 0.3 x 104 cells, P < 0.01 compared with control and LNA alone, Fig. 4C) with no further increase at 48 h (Fig. 4C). The number of apoptotic nuclei per hpf was not different in fetal PAEC exposed to 3% oxygen or room air (2.1 ± 0.7 vs. 2.7 ± 0.7 nuclei/hpf, P = ns). In addition, NOS inhibition did not change the number of apoptotic nuclei in either 3% oxygen (1.7 ± 0.8 nuclei/hpf) or room air (2.6 ± 0.3 nuclei/hpf). There was no change in the ratio of Bax to Bcl-2 in PAEC in room air or 3% oxygen. There was also no change in the Bax to Bcl-2 ratio with NOS inhibition in either room air or 3% oxygen.


Figure 4
View larger version (10K):
[in this window]
[in a new window]
  		Fig. 4. Fetal PAEC growth in RA and 3% oxygen. Ovine PAEC were quiesced in low serum (0.5% FBS) for 48 h and then stimulated with 10% FBS (control, {square}), 10% FBS plus LNA (2 mM, {circ}), and LNA plus SNAP (5 µm, {blacklozenge}). PAEC were grown in RA or in 3% oxygen. A: the rate of increase in cell number in RA was not matched by PAEC exposed to 3% oxygen. B: LNA treatment reduced cell growth RA that was rescued by the addition of SNAP (P < 0.01). C: in 3% oxygen LNA reduced cell growth, which was also reversible by the addition of SNAP (*P < 0.01). SNAP treatment alone in 3% oxygen increases PAEC growth to levels seen in RA. Error bars represent SD from means.

 
NO is required for progression of fetal PAEC through cell cycle. Cell cycle analysis demonstrated differences between PAEC grown in room air vs. 3% oxygen conditions. Under 3% oxygen conditions, a greater percentage of PAEC were in S-phase of the cell cycle at 48 h compared with room air PAEC (20 ± 5% vs. 10 ± 1%; P < 0.05, Fig. 5A). NOS inhibition in room air decreased the percentage of PAEC in S-phase at 24 and 48 h (to 9 ± 0.6% and 6.4 ± 1.6%; P < 0.05, Fig. 5B). NOS inhibition during 3% oxygen exposure decreased the number of S-phase cells at 24 and 48 h (to 8 ± 0.6% and 11.4 ± 3.7%; P < 0.02, Fig. 5C). The addition of SNAP with LNA increased the percentage of PAEC in S-phase at 24 and 48 h in room air compared with LNA alone (to 11.8 ± 0.8% and 10 ± 0.5%; P < 0.05, Fig. 5B). However, SNAP did not increase the percentage of cells in S-phase during exposure to 3% oxygen and LNA (Fig. 5C).


Figure 5
View larger version (12K):
[in this window]
[in a new window]
  		Fig. 5. S-phase of the cell cycle of quiescent ovine fetal PAEC stimulated with 10% serum ({blacksquare}), 10% serum plus LNA (2 mM, {circ}), and 10% serum + LNA (2 mM) + SNAP (5 µm) ({blacktriangledown}). A: there is an increase in the percentage of cells in S-phase in 3% oxygen after 48 h. LNA treatment inhibits the progression of cells through the cell cycle in 3% oxygen (C) and RA (B) (*P < 0.02). The addition of SNAP overcomes the effect of LNA in RA (B) but not in 3% oxygen (C). Error bars represent SD from means.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We report that exposure of fetal PAEC to fetal oxygen tension of 3% oxygen markedly augments tube formation, has little effect on cell migration, and blunts the rate of fetal PAEC proliferation in vitro compared with room air. Interestingly, blockade of NOS by LNA in room air impaired PAEC growth and did not further reduce PAEC tube formation, but the addition of the NO donor SNAP increased fetal PAEC growth rate and improved tube formation to levels seen in the fetal oxygen tension. This suggests that the impairment of tube formation in room air conditions may be due to decreased NO production in fetal PAEC in room air. We further observed that in low oxygen tension the growth and function of fetal PAEC are dependent on functional NOS. Inhibition of NOS with LNA in 3% oxygen impairs fetal PAEC growth, migration, and tube formation. NOS inhibition in 3% oxygen impairs PAEC tube formation to levels seen in room air. The effect of pharmacologic NOS inhibition in a low oxygen tension environment can be reversed by the addition of the NO donor SNAP, suggesting that NO modulates normal fetal PAEC growth and function in low oxygen tension.

The lungs of infants with BPD have been described as having a dysmorphic vascular structure with alveolar simplification and impaired angiogenesis (8, 17). In the premature baboon model of BPD, exposure to mild increases in oxygen tension required to maintain normal oxygenation resulted in abnormalities of alveolar growth and impaired angiogenesis, with a reduction vascular density and a dysmorphic vascular structure (9). In this same model and in the premature sheep model of BPD, there is a reduction of lung eNOS expression (4, 21). Angiogenesis is a process that requires endothelial cells to proliferate, migrate, and form vascular tubes. In this present study, fetal PAEC incubated in low oxygen tension demonstrate a marked improvement in one of these three functions (tube formation). In contrast, room air exposure results in a reduction in number and stability of vascular tubes. Impairment of endogenous NO production during low oxygen tension exposure impairs in vitro angiogenesis by decreasing cell proliferation, impairing PAEC migration, and a reducing vascular tube formation. Exposure of fetal PAEC to the "relative hyperoxia" of room air reduces tube formation to levels observed after NOS inhibition in fetal oxygen tension. This suggests that room air exposure impairs PAEC function in a similar fashion to the effects of NOS inhibition in 3% oxygen. In addition, preliminary experiments (unpublished data) from our lab suggest that NO production during exposure to 3% oxygen is necessary for PAEC progression through the cell cycle, and inhibition of NOS results in G0/G1 arrest. The addition of an exogenous NO donor (SNAP) was able to rescue fetal PAEC from the effects of NOS inhibition under low oxygen conditions. Interestingly, the use of an NO donor also improved fetal PAEC growth and vascular tube formation during exposure to room air. These findings suggest that NO augments cell proliferation, migration, and vascular tube formation in fetal PAEC during culture in 3% oxygen. In addition, the normal low oxygen environment of the fetus is critical for normal PAEC growth and function and that with exposure to relative hyperoxia of room air fetal PAEC proliferation and function is abnormal. Furthermore, during exposure to increased oxygen tension of room air, NO plays a critical role in preserving and promoting cell proliferation and vascular tube formation and migration, the essential elements required for normal blood vessel growth.

The relatively low oxygen tension that the fetus develops (3% oxygen) is essential for normal embryonic growth, including the regression or loss of tissue allowing for normal patterns of organogenesis (7). Low oxygen tension is also involved in the maintenance and establishment of the hemangioblast, the bipotential progenitor of endothelial and hematopoietic cells (27). Low oxygen tension is critical for the stimulation and expression of several proangiogenic factors that include VEGF, platelet-derived growth factor, and hypoxia-inducible factor (HIF)-1{alpha} (22). Fetal lung epithelial cells raised in low oxygen tension have improved plating efficiency and mature rates of lipid synthesis despite preservation of immature morphology (32). The ability of fetal cells in culture to maintain an immature morphology but display mature functions under fetal oxygen tension suggests that the optimal oxygen tension for normal fetal lung growth is the low oxygen environment of the fetus. In fetal lung explants 3% oxygen increases branching of the terminal epithelium and mesenchyme and maintains epithelial differentiation compared with 21% oxygen (14, 33). Van Tuyl and colleagues (33) went further to show that during hypoxia, the disruption of two genes that are involved in hypoxic angiogenesis, HIF-1{alpha} or VEGF, results in dysmorphic lung angiogenesis and that lung vascular development is essential for lung branching morphogenesis. In the higher oxygen concentration of room air, NO has been suggested to aid in the stabilization of HIF-1{alpha} (26), thus abnormalities in NO production could impair angiogenesis via impaired HIF signaling. Our present study is the first to link the improved growth and function, in terms of endothelial tube formation, of fetal PAEC to NO modulation in low oxygen tension. Our study is also the first to suggest that NO may play an adaptive role in the fetal lung exposed to room air by enhancing angiogenesis.

The potential limitations of this study include the possibility that NOS inhibition may have resulted in cell death, although we did not observe an increase in apoptotic nuclei or a shift in the ratio of Bax/Bcl-2 to favor apoptosis. In addition, the effect of NOS inhibition may have increased oxygen radical formation, which could indirectly impair endothelial cell growth and function. Further studies will have to be performed to address the effect of NOS inhibition during hypoxia on apoptosis and superoxide production, in addition to exploring further the role of NO in PAEC cell cycle progression and on the regulatory proteins of cell cycle progression. There exists the possibility that the fetal PAEC phenotype may be affected by isolation and expansion in room air compared with hypoxia. The fetal PAEC used in this study were from large vessels, and there may exist differences in the behavior of these cells compared with microvascular endothelial cells. These potential limitations will be addressed in future studies. Finally, we had difficulties in directly measuring the NOx levels in the cell media, due to relatively high nutrient nitrate levels in the cell culture media (data not shown).

We conclude that endothelially derived NO is essential in preserving PAEC function in vitro, especially when the fetal lung is exposed to the relative hyperoxia of room air. We speculate that exposure of the premature lung to increases in oxygen tension results in impaired angiogenesis, in terms of vascular tube formation, which causes abnormal lung structure. Furthermore, in the lungs of premature infants, reduced endothelial NO production impairs one of the adaptive mechanisms for pulmonary vascular growth in the fetal lung and thus increase the susceptibility for the development of BPD and late pulmonary vascular disease.


   FOOTNOTES
 

Address for reprint requests and other correspondence: V. Balasubramaniam, Pediatric Pulmonary Medicine, Dept. of Pediatrics, UCHSC at Fitzsimmons, Pediatrics 8317, PO Box 6511, Aurora, CO 80045 (e-mail: vivek.balasubramaniam{at}uchsc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Abman SH. Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 619–668.
  2. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis." Am J Respir Crit Care Med 164: 1755–1756, 2001.[Free Full Text]
  3. Acarregui MJ, Penisten ST, Goss KL, Ramirez K, and Snyder JM. Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol 20: 14–23, 1999.[Abstract/Free Full Text]
  4. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, and Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749–L758, 2003.[Abstract/Free Full Text]
  5. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, and Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L964–L971, 2003.[Abstract/Free Full Text]
  6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976.[CrossRef][Web of Science][Medline]
  7. Chen EY, Fujinaga M, and Giaccia AJ. Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology 60: 215–225, 1999.[CrossRef][Web of Science][Medline]
  8. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 85–124.
  9. Coalson JJ, Winter VT, Siler-Khodr T, and Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333–1346, 1999.[Abstract/Free Full Text]
  10. DeMello DE and Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol 3: 439–449, 2000.[CrossRef][Web of Science][Medline]
  11. DeMello DE, Sawyer D, Galvin N, and Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 16: 568–581, 1997.[Abstract]
  12. Dimmeler S, Dernbach E, and Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477: 258–262, 2000.[CrossRef][Web of Science][Medline]
  13. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, and Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604–2609, 2001.[Abstract/Free Full Text]
  14. Gebb SA and Jones PL. Hypoxia and lung branching morphogenesis. Adv Exp Med Biol 543: 117–125, 2003.[Web of Science][Medline]
  15. Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, Post M, and Stewart DJ. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res 94: 1115–1123, 2004.[Abstract/Free Full Text]
  16. Hasan SU and Rigaux A. Arterial oxygen tension threshold range for the onset of arousal and breathing in fetal sheep. Pediatr Res 32: 342–349, 1992.[Web of Science][Medline]
  17. Jobe AH and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723–1729, 2001.[Free Full Text]
  18. Jobe AH. The new BPD: an arrest of lung development. Pediatr Res 46: 641–643, 1999.[Web of Science][Medline]
  19. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188–193, 1975.[Abstract/Free Full Text]
  20. Kroll J and Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743–746, 1998.[CrossRef][Web of Science][Medline]
  21. MacRitchie AN, Albertine KH, Sun J, Lei PS, Jensen SC, Freestone AA, Clair PM, Dahl MJ, Godfrey EA, Carlton DP, and Bland RD. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281: L1011–L1020, 2001.[Abstract/Free Full Text]
  22. Maltepe E and Simon MC. Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J Mol Med 76: 391–401, 1998.[CrossRef][Web of Science][Medline]
  23. Mustonen T and Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895–898, 1995.[Free Full Text]
  24. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9–22, 1999.[Abstract/Free Full Text]
  25. Northway WH Jr, Rosan RC, and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357–368, 1967.[Web of Science][Medline]
  26. Palmer LA, Gaston B, and Johns RA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 58: 1197–1203, 2000.
  27. Ramirez-Bergeron DL, Runge A, Dahl KD, Fehling HJ, Keller G, and Simon MC. Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131: 4623–4634, 2004.[Abstract/Free Full Text]
  28. Risau W. Mechanisms of angiogenesis. Nature 386: 671–674, 1997.[CrossRef][Medline]
  29. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, and Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703–1711, 2000.[Abstract/Free Full Text]
  30. Shen B, Lee DY, and Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 33057–33063, 1999.[Abstract/Free Full Text]
  31. Tallquist MD, Soriano P, and Klinghoffer RA. Growth factor signaling pathways in vascular development. Oncogene 18: 7917–7932, 1999.[CrossRef][Web of Science][Medline]
  32. Tanswell AK, Joneja MG, Possmayer F, and Harding P. Differentiation-arrested rat fetal lung in primary monolayer cell culture. IV. Paradoxical effect of a "fetal" pO2 on precursor incorporation into phospholipids and hormone responsiveness. In Vitro 20: 635–641, 1984.[Web of Science][Medline]
  33. Van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, and Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 288: L167–L178, 2005.[Abstract/Free Full Text]
  34. Wang J, Morita I, Onodera M, and Murota SI. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 190: 238–250, 2002.[CrossRef][Web of Science][Medline]
  35. Wert SE. The lung. In: Fetal and Neonatal Physiology (3rd ed.), edited by Polin RA, Fox WW, and Abman SH. Philadelphia, PA: W. B. Saunders, 2004, p. 783–794.
  36. Yue X and Tomanek RJ. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev Dyn 216: 28–36, 1999.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R.-J. Teng, A. Eis, I. Bakhutashvili, N. Arul, and G. G. Konduri
Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L184 - L195.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P.-H. Rolland, P. de Lagausie, E. Stathopoulos, O. Lepretre, G. Viudes, G. Gorincour, G. Hery, C. de Magnee, O. Paut, and J.-M. Guys
Phasic hemodynamics and reverse blood flows in the aortic isthmus and pulmonary arteries of preterm lambs with pulmonary vascular dysfunction
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2231 - H2241.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. T. Gladwin and D. B. Kim-Shapiro
The functional nitrite reductase activity of the heme-globins
Blood, October 1, 2008; 112(7): 2636 - 2647.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Gien, G. J. Seedorf, V. Balasubramaniam, N. Markham, and S. H. Abman
Intrauterine Pulmonary Hypertension Impairs Angiogenesis In Vitro: Role of Vascular Endothelial Growth Factor Nitric Oxide Signaling
Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1146 - 1153.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/L1111    most recent
00431.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.